EX-99.01 2 dp06999_ex9901.htm
 
EXHIBIT 99.01
 
Hampshire International Business Park
Chineham  Basingstoke
Hampshire RG24 8EP
United Kingdom
Tel +44 (0)1256 894000
Fax +44 (0)1256 894708
www.shire.com
          

 
Press Release
 
Basingstoke, UK and Philadelphia, US – September, 21 2007– Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ)


Notification of major interests in shares

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Shire plc

2. Reason for the notification
State
Yes/No
An acquisition or disposal of voting rights
Yes
An acquisition or disposal of financial instruments which may result in the
acquisition of shares already issued to which voting rights are attached
  
An event changing the breakdown of voting rights
  
Other (please specify):  New Exemption DTR 5.1.3 (4) & DTR 5.1.5 (1)
Yes

3. Full name of person(s) subject to the notification obligation:
The Goldman Sachs Group Inc
4. Full name of shareholder(s) (if different from 3.):
Goldman, Sachs & Co.
Goldman Sachs Financial Markets L.L.C
5. Date of the transaction (and date on which the threshold is crossed
or reached if different):
18 September 2007
6. Date on which issuer notified:
20 September 2007
7. Threshold(s) that is/are crossed or reached:
Below 3%
8. Notified details:
  


A: Voting rights attached to shares
 
 
Registered in England 5492592  Registered Office as above
 
 
Class/type of shares
 if possible using the ISIN CODE
Situation previous to
the Triggering
transaction
Resulting situation after the triggering
transaction
 
Number
of
Shares
Number
of
Voting
Rights
Number
of
shares
Number of voting
rights
% of voting
rights
     
Direct
Direct
Indirect
Direct
Indirect
US82481R1068
15,706,923
(5,235,641 ADRs)
2.835%
          
GB00B0KQX869
1,682,202
0.304%
          
               


B: Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument
Expiration
date
Exercise/Conversion
Period/ Date
Number of voting
rights that may be
acquired if  the instrument
is exercised/converted
% of voting
rights
         


Total (A+B)
  
Number of voting rights
% of voting rights
 
Below 3%


9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

We hereby notify you that as at close of business 18 September 2007 The Goldman Sachs Group Incl, of 85 Broad Street, New York, NY 10004, USA, no longer has a notifiable interest in shares.
 

Proxy Voting:


10. Name of the proxy holder:
N/A
11. Number of voting rights proxy holder will cease to hold:
N/A
12. Date on which proxy holder will cease to hold voting rights:
N/A

13. Additional information:
General Email Contact: shareholderdisclosures@gs.com
14. Contact name:
Joanne Wall/Sean Rogers/Alex Cox
15. Contact telephone number:
44 (20)7051-1704/ 44(20)7552-9205/ 44(20)774-8774

(Contact at Shire plc: Phil Griffin-Smith, Interim Deputy Company Secretary, 01256 894754)
 
 
For further information please contact:

Investor Relations
Cléa Rosenfeld (Rest of the World)
+44 1256 894 160
 
Eric Rojas (North America)
+1 484 595 8252

Notes to editors

SHIRE PLC

Shire’s strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician.  Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic therapies (HGT), gastrointestinal (GI) and renal diseases. The structure is sufficiently flexible to allow Shire to target new therapeutic areas to the extent opportunities arise through acquisitions.  Shire’s in-licensing, merger and acquisition efforts are focused on products in niche markets with strong intellectual property protection either in the US or Europe.  Shire believes that a carefully selected portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.

For further information on Shire, please visit the Company’s website: www.shire.com.

 
 
Registered in England 5492592  Registered Office as above